Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs ciprofol vs propofol plus sufentanil for upper GI endoscopy sedation in older adults
ChiCTR2300074160Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Aug 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing R group (remimazolam + sufentanil), C group (ciprofol + sufentanil) and P group (propofol + sufentanil) (3 arms). Primary endpoint: Incidence rate of hypotension. Started Aug 2023; status: recruiting.
02
Drugs
remimazolamciprofolpropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2300074160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074160.